首页> 美国卫生研究院文献>other >Calcium Binding to Beta-2-Microglobulin at Physiological Ph Drives the Occurrence of Conformational Changes Which Cause the Protein to Precipitate into Amorphous Forms That Subsequently Transform into Amyloid Aggregates
【2h】

Calcium Binding to Beta-2-Microglobulin at Physiological Ph Drives the Occurrence of Conformational Changes Which Cause the Protein to Precipitate into Amorphous Forms That Subsequently Transform into Amyloid Aggregates

机译:钙在生理pH值与β-2-微球蛋白的结合驱动构象变化的发生该构象变化导致蛋白质沉淀为无定形形式随后转变为淀粉样蛋白聚集体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Using spectroscopic, calorimetric and microscopic methods, we demonstrate that calcium binds to beta-2-microglobulin (β2m) under physiological conditions of pH and ionic strength, in biological buffers, causing a conformational change associated with the binding of up to four calcium atoms per β2m molecule, with a marked transformation of some random coil structure into beta sheet structure, and culminating in the aggregation of the protein at physiological (serum) concentrations of calcium and β2m. We draw attention to the fact that the sequence of β2m contains several potential calcium-binding motifs of the DXD and DXDXD (or DXEXD) varieties. We establish (a) that the microscopic aggregation seen at physiological concentrations of β2m and calcium turns into actual turbidity and visible precipitation at higher concentrations of protein and β2m, (b) that this initial aggregation/precipitation leads to the formation of amorphous aggregates, (c) that the formation of the amorphous aggregates can be partially reversed through the addition of the divalent ion chelating agent, EDTA, and (d) that upon incubation for a few weeks, the amorphous aggregates appear to support the formation of amyloid aggregates that bind to the dye, thioflavin T (ThT), resulting in increase in the dye's fluorescence. We speculate that β2m exists in the form of microscopic aggregates in vivo and that these don't progress to form larger amyloid aggregates because protein concentrations remain low under normal conditions of kidney function and β2m degradation. However, when kidney function is compromised and especially when dialysis is performed, β2m concentrations probably transiently rise to yield large aggregates that deposit in bone joints and transform into amyloids during dialysis related amyloidosis.
机译:使用分光光度法,量热法和显微镜方法,我们证明了钙在生理缓冲液的pH和离子强度条件下,在生物缓冲液中与β-2-微球蛋白(β2m)结合,引起构象变化,每个构象变化最多与四个钙原子结合β2m分子具有一些随机的卷曲结构到β折叠结构的显着转变,最终在钙和β2m的生理(血清)浓度下聚集蛋白质。我们提请注意以下事实:β2m序列包含DXD和DXDXD(或DXEXD)变种的几个潜在的钙结合基序。我们确定(a)在生理浓度为β2m和钙的条件下观察到的微观聚集转变为在更高浓度的蛋白质和β2m处的实际浊度和可见沉淀,(b)这种初始聚集/沉淀导致非晶聚集体的形成,( c)通过添加二价离子螯合剂EDTA可以部分逆转无定形聚集体的形成,和(d)孵育数周后,无定形聚集体似乎支持形成结合的淀粉样聚集体染料硫黄素T(ThT),导致染料的荧光增强。我们推测,β2m在体内以微观聚集体的形式存在,并且由于在正常的肾功能和β2m降解条件下蛋白质浓度仍然较低,因此它们不会发展成更大的淀粉样聚集体。但是,当肾脏功能受损时,尤其是在进行透析时,β2m浓度可能会短暂升高,从而产生大的聚集体,这些聚集体沉积在骨关节中,并在与透析相关的淀粉样变性病过程中转化为淀粉样蛋白。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号